Schizophrenia

Monthly extended-release risperidone demonstrated efficacy for improving various schizophrenia symptoms, according to study results published in Journal of Clinical Psychiatry.

Healio Psychiatry has compiled a list of its five most-viewed stories in September.

The transmission of psychiatric disorders to first-degree relatives is higher among those related to patients with bipolar disorders, according to data published in The Journal of Clinical Psychiatry.

Antipsychotic treatment did not increase risk for mortality among adults with serious mental illness diagnosed with COVID-19 infection, according to study results in a research letter published in JAMA Psychiatry.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced FDA approval of Invega Hafyera, a twice-yearly injectable antipsychotic for adults with schizophrenia.

Researchers identified a correlation between low doses of antipsychotics and relapse prevention in schizophrenia, according to findings published in JAMA Psychiatry.

In people with severe psychiatric disorders, psychosocial factors and positive psychology were important in predicting subjective well-being, according to a Spanish study published in Comprehensive Psychiatry.

Individuals with schizophrenia had lower COVID-19 vaccination rates than the general population despite having higher hospitalization and mortality risk, according to results of a longitudinal cohort study.

Schizophrenia genetic liability correlated with higher disorganized dimension scores but not other symptom dimensions, according to results of a genetic association study published in JAMA Psychiatry.

Healio Psychiatry has compiled a list of its five most-viewed stories in July.